Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jessica M Peng"'
Autor:
Paul Saenger, Samuel J. Casella, Wenjie Song, Allison Komirenko, Aristides K Maniatis, Aimee D Shu, Paul S. Thornton, Paul L. Hofman, Gail J. Mick, Ulhas M Nadgir, Jeremy Warshauer, Elena Chertok, Jessica M Peng, Michael Beckert, Elena Aghajanova
Publikováno v:
Journal of the Endocrine Society
Background Once-weekly TransCon hGH is an investigational long-acting prodrug for growth hormone deficiency (GHD) that consists of 3 components: unmodified growth hormone (hGH; somatropin), an inert carrier that protects it, and a linker that tempora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d074e418ef559e9e4e6a94220629ae9
https://doi.org/10.1210/jendso/bvaa046.2102
https://doi.org/10.1210/jendso/bvaa046.2102
Autor:
Aristides K Maniatis, Gail J. Mick, Aimee D Shu, David B Karpf, Wenjie Song, Mary Jennifer Abuzzahab, Larry Deeb, Larry A. Fox, Paul S. Thornton, Paul Saenger, Jessica M Peng, Katie A. Woods, Kent Reifschneider, Ulhas M Nadgir, Samuel J Casella
Publikováno v:
Journal of the Endocrine Society
Background: The Phase 3 fliGHt Trial evaluated children with growth hormone deficiency (GHD) of a broad range of baseline demographics and treatment durations who switched from daily growth hormone (hGH; somatropin) therapy to once-weekly TransCon hG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18cef01ed6feced761a45558d43332c6
https://doi.org/10.1210/jendso/bvaa046.963
https://doi.org/10.1210/jendso/bvaa046.963